Munder Capital Management’s Biogen BIIB Stock Holding History

Munder Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$6.35M	Buy	19,190 +7,065	+58%	+$2.33M	0.05%	281
2014 Q2	$3.82M	Buy	12,125 +11,905	+5,411%	+$3.58M	0.03%	326
2014 Q1	$68K	Buy	+220	New	+$69.8K	﹤0.01%	613
2013 Q3	–	Sell	-15,985	Closed	-$3.44M	–	644
2013 Q2	$3.44M	Buy	+15,985	New	+$3.42M	0.03%	326

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Munder Capital Management's BIIB Position: Q3 2014 in Review

Munder Capital Management increased its Biogen (BIIB) stake by 58% in Q3 2014, buying an estimated $2.33M and bringing the position to 19,190 shares worth $6.35M. The position accounts for 0.05% of the portfolio, ranked #281.

Munder Capital Management first reported a position in BIIB in Q2 2013 and has held it in 4 quarters since. 819 funds tracked by Wall St. Rank hold BIIB as of Q3 2014.

Munder Capital Management held 19,190 shares of Biogen worth $6.35M as of Q3 2014.
Munder Capital Management bought 7,065 Biogen shares in Q3 2014, an estimated $2.33M.
Biogen made up 0.05% of Munder Capital Management's portfolio in Q3 2014, its #281 holding.
Munder Capital Management first reported a position in Biogen in Q2 2013 and has held it in 4 quarters since.
819 funds tracked by Wall St. Rank held Biogen as of Q3 2014.

Based on Munder Capital Management's 13F filing for Q3 2014, filed 31 Oct 2014.